ProPerty, Plant anD equiPment land and machinery and fixtures and projects under buildings vehicles equipment equipment construction total $m $m $m $m $m $m Cost Balance at 1 January 2012 218 15 274 52 67 626 additions 4 1 11 1 33 50 disposals 1 1 10 4 16 transfers 20 15 3 38 translation adjustment 4 2 1 1 8 Balance at 1 January 2013 237 15 288 51 61 652 additions 6 1 14 4 41 66 acquisition of subsidiaries 3 2 1 6 disposals 1 1 3 5 transfers 17 1 24 2 44 translation adjustment 1 3 4 Balance at 31 December 2013 263 16 328 58 58 723 Accumulated Depreciation Balance at 1 January 2012 38 8 127 31 204 charge for the year 9 2 26 6 43 disposals and transfers 1 10 4 15 Balance at 1 January 2013 47 9 143 33 232 charge for the year 10 2 28 7 47 impairment 2 2 disposals 1 2 3 translation adjustment 1 1 2 Balance at 31 December 2013 58 10 170 40 2 280 Carrying amount At 31 December 2013 205 6 158 18 56 443 At 31 December 2012 190 6 145 18 61 420 see note 5 the net book value of the groups property, plant and equipment includes an amount of $10 million 2012: $17 million in respect of assets held under finance lease.
as at 31 December 2013, the group had pledged property, plant and equipment having a carrying value of $49 million 2012: $135 million as collateral for various long-term loans.
this amount includes both specific items around the group and the net property, plant and equipment ofthe groups businesses in Portugal, egypt, germany and tunisia 2012: Portugal, egypt, us, germany and tunisia.
as at 31 December 2013, the group entered into contractual commitments for the acquisition of property, plant and equipment amounting to $18 million 2012: $3 million.
16. investments in associates anD Joint ventures on 18 september 2013, the group signed a 50:50 joint venture Jv agreement with miDroc Pharmaceuticals limited, a member of sheikhmohammed Hussein al amoudis miDroc group miDroc, to establish a presence in the ethiopian pharmaceutical market.
through Hikma cure, Hikma will expand its presence into sub-saharan africa.
expansion into this region is a key strategic priority for Hikma and the Jv is an excellent first step.
Hikma and miDroc will invest in Hikmacure in equal proportions and have committed to provide up to $22 million each in cash, of which $3 million has been paid during the year.
the funds will be invested over time and will be used to build and fit-out a local manufacturing and distribution facility in ethiopia and to provide working capital support for the operations of Hikmacure.
the facility is expected to begin commercial production in 2017.
